DV
Dividend Vision

ICLR — ICON PLC

ICON PLC (ICLR)

Total return is 2465.5% over the past 28.2 years, 1426.2 points ahead of SPY at 1039.3%. Its deepest 1-year drawdown was 60.5%.

ICON PLC is an equity stock that trades as a single company rather than a diversified fund structure. As a clinical research organization, the company provides drug development and trial management services to pharmaceutical and biotechnology clients. The stock does not currently offer a regular dividend distribution, making it oriented toward capital appreciation rather than income generation, and it may appeal primarily to growth-focused investors rather than those seeking dividend yield.

ICLR key facts

Asset type
Stock
Asset class
Equity
Inception date
05/15/1998
Distribution frequency
None
Last close
$163.15
Market cap
$12,587,708,416
Average volume
323800.0
Beta
1.203
Payout ratio
0.0
P/E ratio
251.0
Forward P/E
15.9236
EPS
$0.65